We here demonstrate that, though hypermethylation of certain CpGs in promoter regions of the MMP2, MMP23B, MMP24, MMP25, and MMP28 genes is cancer specific, it lacks independent biological or clinical value, being rather a function from HER2 activation. Here, ERBB2 is linked to cancer.